NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 42 filers reported holding NABRIVA THERAPEUTICS PLC in Q2 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $14,000 | -78.8% | 26,597 | -47.0% | 0.00% | – |
| Q4 2019 | $66,000 | – | 50,186 | +1254550.0% | 0.00% | – |
| Q3 2019 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 4 | -100.0% | 0.00% | – |
| Q1 2019 | $212,000 | +10500.0% | 86,904 | +5791.8% | 0.00% | – |
| Q4 2018 | $2,000 | -92.3% | 1,475 | -84.6% | 0.00% | – |
| Q3 2018 | $26,000 | -64.9% | 9,548 | -55.4% | 0.00% | – |
| Q2 2018 | $74,000 | +111.4% | 21,419 | +199.1% | 0.00% | – |
| Q1 2018 | $35,000 | -93.0% | 7,162 | -91.4% | 0.00% | – |
| Q4 2017 | $499,000 | -26.5% | 83,610 | +0.8% | 0.00% | – |
| Q3 2017 | $679,000 | +62.8% | 82,985 | +108.0% | 0.00% | – |
| Q2 2017 | $417,000 | – | 39,901 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|